OBJECTIVE: This study was designed to explore the acceptability, feasibility, and initial efficacy of a new shelter-based treatment for victims of intimate partner violence (IPV; i.e., Helping to Overcome PTSD through Empowerment [HOPE]). METHOD: A Phase I randomized clinical trial comparing HOPE (n = 35) with standard shelter services (SSS) (n = 35) was conducted. Primary outcome measures included the Clinician-Administered PTSD Scale (CAPS; D. D. Blake et al., 1995) and the Conflict Tactic Scales-Revised (M. A. Straus, S. L. Hamby, S. Boney-McCoy, & D. B. Sugarman, 1996). Participants were followed at 1-week, 3- and 6-months postshelter. RESULTS: Participants reported HOPE to be credible and indicated a high degree of satisfaction with treatment. Only 2 women withdrew from treatment. Both intent to treat (ITT) and minimal attendance (MA) analyses found that HOPE treatment relative to SSS was significantly associated with a lower likelihood of reabuse over the 6-month follow-up period (OR = 5.1, RR = 1.75; OR = 12.6, RR = 3.12, respectively). Results of hierarchical linear model analyses found a significant treatment effect for emotional numbing symptom severity in the ITT sample, t(67) = -2.046, p < .05, and significant treatment effects for effortful avoidance symptom severity, t(49) = -2.506, p < .05, and arousal symptom severity, t(49) = -2.04, p < .05, in the MA sample. Significant effects were also found for depression severity, empowerment, and social support. CONCLUSIONS: Results support the acceptability and feasibility of HOPE and suggest that HOPE may be a promising treatment for IPV victims in shelter. However, results also suggest that modifications to HOPE may be required to improve treatment outcomes.
RCT Entities:
OBJECTIVE: This study was designed to explore the acceptability, feasibility, and initial efficacy of a new shelter-based treatment for victims of intimate partner violence (IPV; i.e., Helping to Overcome PTSD through Empowerment [HOPE]). METHOD: A Phase I randomized clinical trial comparing HOPE (n = 35) with standard shelter services (SSS) (n = 35) was conducted. Primary outcome measures included the Clinician-Administered PTSD Scale (CAPS; D. D. Blake et al., 1995) and the Conflict Tactic Scales-Revised (M. A. Straus, S. L. Hamby, S. Boney-McCoy, & D. B. Sugarman, 1996). Participants were followed at 1-week, 3- and 6-months postshelter. RESULTS:Participants reported HOPE to be credible and indicated a high degree of satisfaction with treatment. Only 2 women withdrew from treatment. Both intent to treat (ITT) and minimal attendance (MA) analyses found that HOPE treatment relative to SSS was significantly associated with a lower likelihood of reabuse over the 6-month follow-up period (OR = 5.1, RR = 1.75; OR = 12.6, RR = 3.12, respectively). Results of hierarchical linear model analyses found a significant treatment effect for emotional numbing symptom severity in the ITT sample, t(67) = -2.046, p < .05, and significant treatment effects for effortful avoidance symptom severity, t(49) = -2.506, p < .05, and arousal symptom severity, t(49) = -2.04, p < .05, in the MA sample. Significant effects were also found for depression severity, empowerment, and social support. CONCLUSIONS: Results support the acceptability and feasibility of HOPE and suggest that HOPE may be a promising treatment for IPV victims in shelter. However, results also suggest that modifications to HOPE may be required to improve treatment outcomes.
Authors: Edward B Blanchard; Edward J Hickling; Trishul Devineni; Connie H Veazey; Tara E Galovski; Elizabeth Mundy; Loretta S Malta; Todd C Buckley Journal: Behav Res Ther Date: 2003-01
Authors: Edna B Foa; Elizabeth A Hembree; Shawn P Cahill; Sheila A M Rauch; David S Riggs; Norah C Feeny; Elna Yadin Journal: J Consult Clin Psychol Date: 2005-10
Authors: Candice M Monson; Paula P Schnurr; Patricia A Resick; Matthew J Friedman; Yinong Young-Xu; Susan P Stevens Journal: J Consult Clin Psychol Date: 2006-10
Authors: G Ironson; C Wynings; N Schneiderman; A Baum; M Rodriguez; D Greenwood; C Benight; M Antoni; A LaPerriere; H S Huang; N Klimas; M A Fletcher Journal: Psychosom Med Date: 1997 Mar-Apr Impact factor: 4.312
Authors: Edward S Kubany; Elizabeth E Hill; Julie A Owens; Cindy Iannce-Spencer; Mari A McCaig; Ken J Tremayne; Paulette L Williams Journal: J Consult Clin Psychol Date: 2004-02
Authors: Patricia A Resick; Tara E Galovski; Mary O'Brien Uhlmansiek; Christine D Scher; Gretchen A Clum; Yinong Young-Xu Journal: J Consult Clin Psychol Date: 2008-04
Authors: Nicole H Weiss; Aaron A Duke; Nicole M Overstreet; Suzanne C Swan; Tami P Sullivan Journal: Aggress Behav Date: 2015-12-24 Impact factor: 2.917
Authors: Dawn M Johnson; Patrick A Palmieri; Caron Zlotnick; Nicole L Johnson; Lesa Hoffman; Samantha C Holmes; Taylor L Ceroni Journal: Psychol Women Q Date: 2020-09-17